Xavier Bosch, MD
According to the Centers for Disease Control and Prevention, incidence rates of HPV-associated cancers continue to rise, with approximately 39,000 new HPV-associated cancers now diagnosed annually in the United States.
, Bosch, a senior consultant at the Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d' Oncologia–Catalan Institute of Oncology, discussed a second-generation vaccination against HPV for the prevention of cervical cancer.
OncLive: Can you discuss the HPV vaccination for cervical cancer prevention in Europe?
: These second-generation vaccines have the ability to protect against 7 HPV types that cause cervical cancer and a number of other cancers in males and females.
... to read the full story